The $ 300 clinical trials market is expected to grow at an annual growth rate of 15 % over the next 4 years at top official of Institute of Clinical Research India (ICRI) said. This will bring nearly 15 % of total global clinical trials to Indiaby 2011 and will generate an annual revenue of $ 1 billion, ICRI's Chief Executive Officer Antony Woodman Said "Currently there are 268 approved clinical trials in India, as compared to a global total of 180,000. The value of current clinical trials in India is $ 300 million" he said. However a lack of competent personnel in the country and appropriate research infrastructure are posing major challenges to rowth, woodman said
Source Economic Times Monday November 19 New Delhi
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment